Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Huber

Showing results (421-430 of 927) with videos related to

Pageof 93
Sort By:
In Vivo (Athens, Greece)|May 2, 2020
Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate CancerFelix Zwicker, Benedict Swartman, Peter E Huber, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2017
Isomer Selectivity in Low-Energy Electron Attachment to NitroimidazolesAnita Ribar, Katharina Fink, Michael Probst, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 12, 2002
Single breath-hold extended free-breathing navigator-gated three-dimensional coronary MRAMichael E Huber, Markus E Oelhafen, Sebastian Kozerke, et al.
The Journal of Biological Chemistry|June 5, 1992
A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUAH W Gaugitsch, E E Prieschl, F Kalthoff, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2009
Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomasStephanie E Combs, Thomas Welzel, Daniela Schulz-Ertner, et al.
British Journal of Pharmacology|February 1, 1996
Inhibition of prostanoid formation in intact cells by 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a blocker of Ca(2+)-ATPasesH J Leis, D Zach, E Huber, et al.
Biochemistry|September 24, 1996
Structure-reactivity relationships for beta-galactosidase (Escherichia coli, lac Z). 4. Mechanism for reaction of nucleophiles with the galactosyl-enzyme intermediates of E461G and E461Q beta-galactosidasesJ P Richard, R E Huber, C Heo, et al.
Biosensors & Bioelectronics|July 6, 2025
Electrokinetic nanofluidic sensing of DNA nanostar condensateKuang-Hua Chou, Alexander Eden, David E Huber, et al.
Faraday Discussions|May 20, 2024
Dynamics of carbene formation in the reaction of methane with the tantalum cation in the gas phaseMarcel Meta, Maximilian E Huber, Maurice Birk, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|March 17, 1992
[Movement therapy. With special reference to functional disorders of the locomotor system]M Oliveri, U Gamper, H Hagmann, et al.
Pageof 93

Showing results (421-430 of 927) with videos related to

Sort By:
Pageof 93
In Vivo (Athens, Greece)|May 2, 2020
Lack of Relevant Haemogram Changes During Percutaneous Radiotherapy of Localised Prostate CancerFelix Zwicker, Benedict Swartman, Peter E Huber, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 12, 2017
Isomer Selectivity in Low-Energy Electron Attachment to NitroimidazolesAnita Ribar, Katharina Fink, Michael Probst, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 12, 2002
Single breath-hold extended free-breathing navigator-gated three-dimensional coronary MRAMichael E Huber, Markus E Oelhafen, Sebastian Kozerke, et al.
The Journal of Biological Chemistry|June 5, 1992
A novel transiently expressed, integral membrane protein linked to cell activation. Molecular cloning via the rapid degradation signal AUUUAH W Gaugitsch, E E Prieschl, F Kalthoff, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2009
Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomasStephanie E Combs, Thomas Welzel, Daniela Schulz-Ertner, et al.
British Journal of Pharmacology|February 1, 1996
Inhibition of prostanoid formation in intact cells by 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a blocker of Ca(2+)-ATPasesH J Leis, D Zach, E Huber, et al.
Biochemistry|September 24, 1996
Structure-reactivity relationships for beta-galactosidase (Escherichia coli, lac Z). 4. Mechanism for reaction of nucleophiles with the galactosyl-enzyme intermediates of E461G and E461Q beta-galactosidasesJ P Richard, R E Huber, C Heo, et al.
Biosensors & Bioelectronics|July 6, 2025
Electrokinetic nanofluidic sensing of DNA nanostar condensateKuang-Hua Chou, Alexander Eden, David E Huber, et al.
Faraday Discussions|May 20, 2024
Dynamics of carbene formation in the reaction of methane with the tantalum cation in the gas phaseMarcel Meta, Maximilian E Huber, Maurice Birk, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|March 17, 1992
[Movement therapy. With special reference to functional disorders of the locomotor system]M Oliveri, U Gamper, H Hagmann, et al.
Pageof 93